These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 18670424)

  • 1. Pharma pursues novel models for academic collaboration.
    Hughes B
    Nat Rev Drug Discov; 2008 Aug; 7(8):631-2. PubMed ID: 18670424
    [No Abstract]   [Full Text] [Related]  

  • 2. The future is much closer collaboration between the pharmaceutical industry and academic medical centers.
    Vallance P; Williams P; Dollery C
    Clin Pharmacol Ther; 2010 May; 87(5):525-7. PubMed ID: 20407455
    [No Abstract]   [Full Text] [Related]  

  • 3. Conflict of interest or productive collaboration? The pharma: academic relationship and its implications for headache medicine.
    Finkel AG
    Headache; 2006; 46(7):1181-5. PubMed ID: 16866722
    [No Abstract]   [Full Text] [Related]  

  • 4. Demystifying industry-academia collaboration.
    Gersdorf T; He VF; Schlesinger A; Koch G; Ehrismann D; Widmer H; von Krogh G
    Nat Rev Drug Discov; 2019 Sep; 18(10):743-744. PubMed ID: 31570836
    [No Abstract]   [Full Text] [Related]  

  • 5. How academia and the pharmaceutical industry can work together: the president's lecture, annual meeting of the American Thoracic Society, San Francisco, California.
    Rosenblatt M
    Ann Am Thorac Soc; 2013 Feb; 10(1):31-8. PubMed ID: 23509330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outlook: finding improved medicines: the role of academic-industrial collaboration.
    Chin-Dusting J; Mizrahi J; Jennings G; Fitzgerald D
    Nat Rev Drug Discov; 2005 Nov; 4(11):891-7. PubMed ID: 16247439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of academic health centers in improving health.
    Roper WL; Newton WP
    Ann Fam Med; 2006; 4 Suppl 1(Suppl 1):S55-7; discussion S58-60. PubMed ID: 17003165
    [No Abstract]   [Full Text] [Related]  

  • 8. Industry support for medical centers grows.
    Dove A
    Nat Med; 2000 Sep; 6(9):948. PubMed ID: 10973295
    [No Abstract]   [Full Text] [Related]  

  • 9. EUFEPS report. Contribution of academic research to discovery and development of medicines: current status and future opportunities.
    Couvreur P; Barguer D; Crommelin DJ; Duchêne D; Engels JW; Kerr DJ; Krogsgaard-Larsen P; Meijer DK; Paoletti R; Wagner E;
    Eur J Pharm Sci; 2005 Feb; 24(2-3):245-52. PubMed ID: 15776539
    [No Abstract]   [Full Text] [Related]  

  • 10. Collaboration between academia and pharma to bring new therapies to market more important than ever.
    Caffrey MK
    Am J Manag Care; 2014 Feb; 20(2 Spec No.):E14. PubMed ID: 25764579
    [No Abstract]   [Full Text] [Related]  

  • 11. An audience with... Susan Desmond-Hellmann. Interview by... Asher Mullard.
    Desmond-Hellmann S
    Nat Rev Drug Discov; 2011 Mar; 10(3):170. PubMed ID: 21358729
    [No Abstract]   [Full Text] [Related]  

  • 12. Collaborations between academic psychiatry and the pharmaceutical industry: a perspective from industry.
    Tohen M
    Epidemiol Psichiatr Soc; 2007; 16(3):197-8. PubMed ID: 18020191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arguments against precompetitive collaboration.
    Vargas G; Boutouyrie B; Ostrowitzki S; Santarelli L
    Clin Pharmacol Ther; 2010 May; 87(5):527-9. PubMed ID: 20407456
    [No Abstract]   [Full Text] [Related]  

  • 14. Sharing pharma compounds with academia: experiences with providing vitamin D receptor ligands.
    Schmitz AA; Hackethal S; Schulz A; May E; Steinmeyer A; Zügel U; Asadullah K
    Nat Rev Drug Discov; 2015 Apr; 14(4):294. PubMed ID: 25743082
    [No Abstract]   [Full Text] [Related]  

  • 15. Building bridges between academia and industry: forms; foundations; functions.
    Bander KW; Rosenberg LE
    Yale J Biol Med; 1997; 70(3):213-7. PubMed ID: 9544491
    [No Abstract]   [Full Text] [Related]  

  • 16. The Biomarkers Consortium: practice and pitfalls of open-source precompetitive collaboration.
    Wagner JA; Prince M; Wright EC; Ennis MM; Kochan J; Nunez DJ; Schneider B; Wang MD; Chen Y; Ghosh S; Musser BJ; Vassileva MT
    Clin Pharmacol Ther; 2010 May; 87(5):539-42. PubMed ID: 20407460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How informatics can potentiate precompetitive open-source collaboration to jump-start drug discovery and development.
    Perakslis ED; Van Dam J; Szalma S
    Clin Pharmacol Ther; 2010 May; 87(5):614-6. PubMed ID: 20376001
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharma and Academia: What We Have Here Is a Failure to Communicate.
    Birnbaum MJ
    Cell Metab; 2016 Sep; 24(3):365-367. PubMed ID: 27626193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The patient-physician-industry-government partnership: a societal good.
    Frishman WH
    Am J Med; 2009 Oct; 122(10):886-7. PubMed ID: 19786152
    [No Abstract]   [Full Text] [Related]  

  • 20. The changing academic medical center.
    Kirsner JB
    Perspect Biol Med; 2005; 48(3):472-4. PubMed ID: 16086001
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.